OSANG HEALTHCARE CO.,LTD Osang Healthcare Co.,Ltd Share Price
Equities
A036220
KR7036220002
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,420 KRW | +0.83% |
|
+0.98% | +283.43% |
| 17/06 | Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares. | CI |
| 17/06 | Osang Healthcare Co.,Ltd authorizes a Buyback Plan. | CI |
| Sales 2022 | 194B 140M 11.7B | Sales 2023 | 356B 258M 21.47B | Capitalization | 34.88B 25.25M 2.1B |
|---|---|---|---|---|---|
| Net income 2022 | 40.65B 29.43M 2.45B | Net income 2023 | 116B 84.3M 7.02B | EV / Sales 2022 | -0.13 x |
| Net cash position 2022 | 60.43B 43.75M 3.65B | Net cash position 2023 | 143B 104M 8.63B | EV / Sales 2023 | -0.3 x |
| P/E ratio 2022 |
1.1
x | P/E ratio 2023 |
0.39
x | Employees | 314 |
| Yield 2022 |
85.7% | Yield 2023 |
57.1% | Free-Float | 36.37% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.83% | ||
| 1 week | +0.98% | ||
| Current month | +0.83% | ||
| 1 month | -6.61% | ||
| 3 months | -46.75% | ||
| 6 months | +283.43% | ||
| Current year | +283.43% |
1 week
13 090.00
13 590.00
1 month
13 090.0014 370.00
Current year
13 090.0045 000.00
1 year
13 090.0045 000.00
3 years
13 090.0045 000.00
5 years
13 090.0045 000.00
10 years
2 095.0045 000.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/24/17 | 13,420 | +0.83% | 30,672 |
| 14/24/14 | 13,310 | -0.89% | 18,859 |
| 13/24/13 | 13,430 | +1.97% | 28,064 |
| 12/24/12 | 13,170 | +0.15% | 22,618 |
| 11/24/11 | 13,150 | -1.05% | 17,738 |
End-of-day quote Korea S.E., June 17, 2024
More quotes
Osang HealthCare Co Ltd is a Korea-based company primarily engaged in research and development of in vitro diagnostic medical devices. The Company operates through three segments. The Biochemical Diagnostic segment mainly develops products such as personal blood sugar measurement devices, glycated hemoglobin measurement devices, cholesterol measurement devices, liver disease measurement devices, and U-healthcare devices. The Immunodiagnostic segment is mainly engaged in the development of immunodiagnostic devices and measurement sensors. The Molecular Diagnostic segment mainly engages in the development of molecular diagnostic devices and reagents.
| 1st Jan change | Capi. | |
|---|---|---|
| +283.43% | 136M | |
| -8.90% | 11.5B | |
| -7.90% | 7.8B | |
| +32.85% | 5.73B | |
| -14.93% | 3.88B | |
| +8.42% | 2.61B | |
| -64.06% | 2.39B | |
| -11.04% | 2.23B | |
| +23.88% | 2.17B | |
| -9.61% | 1.76B |
- Stock Market
- Equities
- A036220 Stock
